Search

Carlos Corvera Phones & Addresses

  • Gardena, CA
  • 1034 109Th St, Los Angeles, CA 90044 (323) 779-3097
  • El Verano, CA

Professional Records

Medicine Doctors

Carlos Corvera Photo 1

Carlos U. Corvera

View page
Specialties:
General Surgery
Work:
UCSF Helen Diller Family Comprehensive Cancer Center
1825 4 St FL 4, San Francisco, CA 94143
(415) 353-9888 (phone), (415) 353-7150 (fax)

San Francisco VA Surgery Clinic
401 43 Ave APT 112, San Francisco, CA 94121
(415) 221-4810 (phone), (415) 750-2181 (fax)
Education:
Medical School
University of California, San Diego School of Medicine
Graduated: 1993
Procedures:
Bariatric Surgery
Endoscopic Retrograde Cholangiopancreatography (ERCP)
Gallbladder Removal
Liver Transplant
Thoracoscopy
Tracheostomy
Hernia Repair
Laparoscopic Gallbladder Removal
Small Bowel Resection
Conditions:
Cholelethiasis or Cholecystitis
Gastric Cancer
Liver Cancer
Malignant Neoplasm of Colon
Malignant Neoplasm of Female Breast
Languages:
English
Spanish
Description:
Dr. Corvera graduated from the University of California, San Diego School of Medicine in 1993. He works in San Francisco, CA and 1 other location and specializes in General Surgery. Dr. Corvera is affiliated with San Francisco VA Medical Center, UCSF Medical Center Mount Zion and UCSF Medical Center Parnassus.

Publications

Us Patents

Ileus Treatment Method

View page
US Patent:
58885293, Mar 30, 1999
Filed:
Mar 28, 1997
Appl. No.:
8/828953
Inventors:
Nigel W. Bunnett - Sausalito CA
Carlos U. Corvera - San Francisco CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 908
US Classification:
424422
Abstract:
A method of treating or preventing post-operative ileus in a mammalian subject is disclosed. The method involves administering to the subject, a pharmaceutically effective amount of a compound that is effective in (i) preventing mast cell degranulation, (ii) inhibiting tryptase and chymase, and (iii) antagonizing PAR-2. The treatment is based on the discoveries that proteinase-activated receptor 2 is expressed in colonic muscle cells, and that activation of PAR-2 inhibits colonic motility. The PAR-2 receptor is activated, at least in part, by tryptase and chymase, produced by infiltration and degranulation of mast cells.

Ileus Treatment Method

View page
US Patent:
59584076, Sep 28, 1999
Filed:
Mar 27, 1998
Appl. No.:
9/049662
Inventors:
Nigel W. Bunnett - Sausalito CA
Carlos U. Corvera - San Francisco CA
Assignee:
The Regents of the Uinversity of California - San Francisco CA
International Classification:
A61K 3848
US Classification:
424 9464
Abstract:
A method of treating or preventing post-operative ileus in a mammalian subject is disclosed. The method involves administering to the subject, a pharmaceutically effective amount of a compound that is effective in (i) preventing mast cell degranulation, (ii) inhibiting tryptase and chymase, and (iii) antagonizing PAR-2. The treatment is based on the discoveries that proteinase-activated receptor 2 is expressed in colonic muscle cells, and that activation of PAR-2 inhibits colonic motility. The PAR-2 receptor is activated, at least in part, by tryptase and chymase, produced by infiltration and degranulation of mast cells.
Carlos A Corvera from Gardena, CA, age ~49 Get Report